PERRIGO Co plc
About PERRIGO Co plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $4.3B
- Net income
- -$1.4B
- Total assets
- $8.5B
- Market cap
- $1.5B
- Gross margin
- 35.1%
- Operating margin
- -26.4%
- Net margin
- -33.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.3B
- Cost of revenue
- $2.8B
- Gross profit
- $1.5B
- Operating expenses
- $2.6B
- Operating income
- -$1.1B
- Income tax
- $104.4M
- Net income
- -$1.4B
- EPS (basic)
- $-10.29
- EPS (diluted)
- $-10.29
Balance sheet
- Total assets
- $8.5B
- Current assets
- $2.8B
- Total liabilities
- $5.6B
- Current liabilities
- $1.0B
- Shareholders’ equity
- $2.9B
Cash flow
- Operating cash flow
- $238.5M
- Investing cash flow
- -$75.4M
- Financing cash flow
- -$220.5M
- Net cash flow
- -$57.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.5B
- EPS (diluted)
- $-10.29
- Dividend yield
- 9.99%
- Shares outstanding
- 129.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 16, 1991
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $1.4B in FY2025.
- Revenue grew 3% from FY2021 to FY2025.
- Gross margin of 35.1%, net margin -33.5%.
- Trading 59% below its 52-week high.
- Pays a dividend yielding about 9.99% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PERRIGO Co plc.
Write a review
News about PERRIGO Co plc
News & sentiment via Polygon.io
